QualityStocksNewsBreaks Archives - Page 5 of 1470

ThursdayDec 04, 2025 9:00 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) Plans $1.12M Non-Brokered Private Placement

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) announces plans to raise up to $1.12 million through a non-brokered private placement of up to 2,000,000 flow-through units priced at $0.56 each. Each unit includes one flow-through common share and one-half warrant, with whole warrants exercisable at $0.65 for 36 months. Proceeds will be used for qualifying Canadian exploration expenses under the Income Tax Act. The placement is subject to customary closing conditions, includes a four month and one day hold period, and may involve 6% cash…

ThursdayDec 04, 2025 9:00 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Forms Massimo AI Technology to Expand into Robotics Markets

Massimo Group (NASDAQ: MAMO) has established Massimo AI Technology Inc., a wholly owned subsidiary created to advance the company into industrial and service robotics while supporting its long-term technology roadmap. The new division will develop practical automation and warehouse-assistance platforms, build a dedicated robotics supply and manufacturing foundation, and leverage Massimo’s existing strengths in electric systems and global operations. Leadership says the initiative broadens the company’s technology base, opens potential entry into high-growth automation sectors, and supports diversified long-term revenue opportunities. To view the full press release, visit https://ibn.fm/2P71E About Massimo Group (NASDAQ: MAMO) Massimo Group is a manufacturer and distributor…

WednesdayDec 03, 2025 3:34 pm

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance

Safe Pro Group (NASDAQ: SPAI), a mission-driven provider of AI-powered defense and security solutions, is aligned with a major federal shift as the War Department moves to acquire roughly 300,000 low-cost drones under President Trump’s “Unleashing American Drone Dominance” initiative. The department’s new request for information outlines a $1 billion procurement program beginning in early 2026 that will fund four production “gauntlets,” starting with 12 vendors delivering 30,000 drones at $5,000 per unit and scaling toward 150,000 units at reduced costs. Secretary of War Pete Hegseth said the program aims to rebuild U.S. industrial capacity, integrate unmanned systems into all…

WednesdayDec 03, 2025 3:30 pm

QualityStocksNewsBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Prices $72.8 Million IPO

Gloo (NASDAQ: GLOO) , a technology platform serving the faith and flourishing ecosystem, priced its initial public offering of 9,100,000 shares of Class A common stock at $8 per share and granted underwriters a 30-day option to purchase up to 1,365,000 additional shares. Trading is expected to begin on the Nasdaq Global Select Market under the symbol GLOO, with the offering slated to close Nov. 20, 2025, subject to customary conditions. Roth Capital Partners is serving as sole book-running manager, with The Benchmark Company, Craig-Hallum Capital Group, Lake Street Capital Markets, Loop Capital Markets, and Texas Capital Securities acting as…

WednesdayDec 03, 2025 2:33 pm

QualityStocksNewsBreaks – Decent Holding Inc. (NASDAQ: DXST) Closes $8 Million Registered Offering of Class A Shares and Warrants

Decent Holding (NASDAQ: DXST), an established wastewater treatment services provider in China, closed its $8 million registered offering consisting of 13,333,333 Class A ordinary shares at $0.60 per share and warrants to purchase 26,666,666 additional shares at 110 percent of the offering price with a 120-day term. Gross proceeds totaled $8 million before expenses, and the company plans to use the net proceeds to support business expansion, R&D, river-water quality management initiatives, wastewater treatment technology upgrades, and talent recruitment. The offering was conducted on a reasonable best-effort basis, with D. Boral Capital LLC serving as placement agent. To view the…

WednesdayDec 03, 2025 12:26 pm

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% JV Reports IV Sapu003 Cuts GI Exposure to Everolimus by Up to 67-Fold

Oncotelic Therapeutics (OTCQB: OTLC), 45% owner of the Sapu Nano joint venture, announced new pharmacokinetic and tissue-distribution data showing that Sapu003, its intravenous Deciparticle (TM) formulation of everolimus, dramatically reduces gastrointestinal drug accumulation compared with oral everolimus. Oral dosing drives extreme gut exposure—up to 2,448× plasma levels in the stomach—while IV Sapu003 limits GI tissue levels to just 36–48× plasma, representing reductions of up to 67-fold. The company stated that this shift may improve tolerability, maintain the drug’s intrinsic metabolic profile, and provide more consistent systemic exposure. To view the full press release, visit https://ibn.fm/TWsDZ About Oncotelic Therapeutics Inc. Oncotelic Therapeutics…

WednesdayDec 03, 2025 11:45 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Details Encouraging LP-184 Phase 1a Results Showing Durable Disease Control in Advanced Solid Tumors

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company using artificial intelligence and genomics to transform oncology drug development, reported additional details and clinical insights from its completed Phase 1a dose-escalation study of LP-184 along with highlights from a recent webinar. The study in 63 heavily pre-treated patients with advanced solid tumors met all primary endpoints for safety and tolerability and established a clear recommended Phase 2 dose. Encouraging signals of durable disease control were observed, particularly in tumors with DNA damage repair pathway deficiencies. Building on these results, Lantern is advancing multiple biomarker-guided Phase 1b/2 trials across triple-negative breast cancer,…

WednesdayDec 03, 2025 11:44 am

QualityStocksNewsBreaks – Micropolis AI Robotics (NYSE: MCRP) Signs LOI With QSS Robotics to Expand Deployment in Saudi Arabia

Micropolis AI Robotics (NYSE American: MCRP), a UAE-based developer of autonomous mobile robots and AI-driven security solutions, said it signed a non-binding Letter of Intent with QSS Robotics to establish a strategic collaboration for the distribution, localization, and deployment of Micropolis technologies across Saudi Arabia. The LOI outlines plans for commercial representation, joint engagement with government and private-sector customers, and integration and after-sales support under Micropolis supervision, building on agreements between the companies dating to 2022. Micropolis will provide its full suite of technologies, including M01 and M02 autonomous mobility platforms, Mission Planner and HD Mapping systems, Tele-Operator tools, and…

WednesdayDec 03, 2025 11:29 am

QualityStocksNewsBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Reaches Agreement With Major Central American Grocer to Deploy Smart Cart Platform

A2Z Cust2Mate Solutions (NASDAQ: AZ), a global smart retail technology company, said it entered an agreement with a premium grocery retailer operating more than 50 stores in Central America to deploy the A2Z Cust2mate smart cart platform. Initial rollout is planned for early 2026 in two flagship locations, with the shared goal of expanding to a full chain-wide deployment following successful implementation. The Company said the agreement marks a significant milestone for large-scale smart cart adoption in Central America, supported by its regional channel partner Trixo, and will help redefine the in-store experience, enhance retail media opportunities, and generate new…

WednesdayDec 03, 2025 10:15 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial Highlighting HyBryte(TM) and Rare Disease Policy

Soligenix (NASDAQ: SNGX) was featured in a BioMedWire editorial titled “Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now,” which examines the growing burden of rare diseases affecting more than 30 million Americans and the urgent need for new therapies. The article spotlights Soligenix’s late-stage development of HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma, now in its final confirmatory study before worldwide marketing submissions, and places the Company’s efforts at the intersection of advancing treatment options and emerging national health policy initiatives. To view the full press release, visit https://ibn.fm/OFZZt About Soligenix Soligenix is a…

Site Search

Company Search

Category: QualityStocksNewsBreaks